ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for ADMA

Stock NameADMA Biologics Inc
TickerADMA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS0008991046

Show aggregate ADMA holdings

News associated with ADMA

Charles Schwab Investment Management Inc. Raises Position in ADMA Biologics Inc (NASDAQ:ADMA)
Charles Schwab Investment Management Inc. boosted its stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The institutional investor owned 2,462,005 shares of the biotechnology company’s stock after buying an additional 21,711 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in ADMA Biologics were worth […] - 2025-08-17 06:22:54
PNC Financial Services Group Inc. Increases Stake in ADMA Biologics Inc (NASDAQ:ADMA)
PNC Financial Services Group Inc. raised its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 24.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,325 shares of the biotechnology company’s stock after acquiring an additional 4,553 shares during the […] - 2025-08-14 04:55:07
Harvest Fund Management Co. Ltd Takes Position in ADMA Biologics Inc (NASDAQ:ADMA)
Harvest Fund Management Co. Ltd bought a new stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) during the first quarter, Holdings Channel reports. The fund bought 2,611 shares of the biotechnology company’s stock, valued at approximately $52,000. A number of other hedge funds and other institutional investors have also recently made changes […] - 2025-08-01 05:32:51
ADMA Biologics Inc (NASDAQ:ADMA) Shares Acquired by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. boosted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 14.5% in the first quarter, HoldingsChannel reports. The firm owned 68,686 shares of the biotechnology company’s stock after purchasing an additional 8,682 shares during the quarter. Envestnet Asset Management Inc.’s holdings in ADMA Biologics were worth $1,363,000 […] - 2025-08-01 04:36:52
Skandinaviska Enskilda Banken AB publ Invests $35,000 in ADMA Biologics Inc (NASDAQ:ADMA)
Skandinaviska Enskilda Banken AB publ purchased a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) in the first quarter, HoldingsChannel reports. The firm purchased 1,773 shares of the biotechnology company’s stock, valued at approximately $35,000. A number of other hedge funds have also modified their holdings of ADMA. Vanguard Group Inc. […] - 2025-07-31 05:57:11
Avantax Advisory Services Inc. Has $2.15 Million Stake in ADMA Biologics Inc (NASDAQ:ADMA)
Avantax Advisory Services Inc. lifted its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 1.8% during the 1st quarter, HoldingsChannel reports. The fund owned 108,327 shares of the biotechnology company’s stock after purchasing an additional 1,954 shares during the period. Avantax Advisory Services Inc.’s holdings in ADMA Biologics were worth $2,149,000 […] - 2025-07-31 05:16:47
Cerity Partners LLC Acquires 4,575 Shares of ADMA Biologics Inc (NASDAQ:ADMA)
Cerity Partners LLC boosted its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 10.6% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 47,703 shares of the biotechnology company’s stock after buying an additional 4,575 shares during the quarter. Cerity Partners LLC’s holdings in ADMA Biologics were worth $946,000 as […] - 2025-07-24 04:32:54
ADMA Biologics Inc (NASDAQ:ADMA) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC lessened its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 3.9% during the 1st quarter, Holdings Channel reports. The firm owned 34,423 shares of the biotechnology company’s stock after selling 1,384 shares during the quarter. Mutual of America Capital Management LLC’s holdings in ADMA Biologics […] - 2025-07-22 07:10:54
Bank of New York Mellon Corp Decreases Holdings in ADMA Biologics Inc (NASDAQ:ADMA)
Bank of New York Mellon Corp cut its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 3.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,468,609 shares of the biotechnology company’s stock after selling 52,557 shares during the quarter. Bank […] - 2025-07-17 04:42:50
ADMA Biologics Inc (NASDAQ:ADMA) Shares Acquired by Principal Financial Group Inc.
Principal Financial Group Inc. boosted its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 2.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,288,121 shares of the biotechnology company’s stock after purchasing an additional 29,107 […] - 2025-07-09 05:45:05
Robeco Institutional Asset Management B.V. Boosts Holdings in ADMA Biologics Inc (NASDAQ:ADMA)
Robeco Institutional Asset Management B.V. lifted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 48.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 258,609 shares of the biotechnology company’s stock after buying an additional 84,125 shares during the […] - 2025-07-01 05:25:03
ADMA Biologics Inc (NASDAQ:ADMA) Shares Sold by Illinois Municipal Retirement Fund
Illinois Municipal Retirement Fund decreased its position in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 17.3% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 105,223 shares of the biotechnology company’s stock after selling 21,937 shares during the period. Illinois Municipal Retirement Fund’s holdings in ADMA […] - 2025-06-30 05:38:52
Moran Wealth Management LLC Invests $795,000 in ADMA Biologics Inc (NASDAQ:ADMA)
Moran Wealth Management LLC purchased a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 40,056 shares of the biotechnology company’s stock, valued at approximately $795,000. A number of other large investors […] - 2025-06-27 05:14:54
State of Alaska Department of Revenue Sells 3,365 Shares of ADMA Biologics Inc (NASDAQ:ADMA)
State of Alaska Department of Revenue reduced its stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 2.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 130,981 shares of the biotechnology company’s stock after selling 3,365 shares during the period. […] - 2025-06-23 04:46:52
ADMA Biologics Inc (NASDAQ:ADMA) Director Sells $3,941,719.76 in Stock
ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) Director Steve Elms sold 194,749 shares of the business’s stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $20.24, for a total transaction of $3,941,719.76. Following the transaction, the director now owns 87,330 shares in the company, valued at […] - 2025-06-20 05:14:53
Insider Selling: ADMA Biologics Inc (NASDAQ:ADMA) Director Sells 137,931 Shares of Stock
ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) Director Steve Elms sold 137,931 shares of ADMA Biologics stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $20.82, for a total value of $2,871,723.42. Following the completion of the sale, the director now owns 282,079 shares of the […] - 2025-06-19 05:11:05
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 6.8% on Insider Selling
ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) shares traded down 6.8% on Tuesday following insider selling activity. The company traded as low as $19.17 and last traded at $19.01. 1,700,847 shares traded hands during trading, a decline of 54% from the average session volume of 3,667,821 shares. The stock had previously closed at $20.40. […] - 2025-06-19 02:13:07
SPYV, SAWS: Big ETF Inflows
Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the SPDR Portfolio S&P 500 Value ETF, which added 14,400,000 units, or a 2.8% increase week over week. Among the largest underlying components of - 2025-06-11 13:09:49
Rhumbline Advisers Buys 1,088 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
Rhumbline Advisers raised its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.2% in the 1st quarter, Holdings Channel reports. The firm owned 622,167 shares of the biotechnology company’s stock after purchasing an additional 1,088 shares during the quarter. Rhumbline Advisers’ holdings in ADMA Biologics were worth $12,344,000 at the end […] - 2025-06-09 05:26:49
Wellington Management Group LLP Sells 13,834 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
Wellington Management Group LLP lessened its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 11.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 105,459 shares of the biotechnology company’s stock after selling 13,834 shares during the quarter. Wellington Management Group […] - 2025-06-06 05:04:51
California State Teachers Retirement System Acquires 8,717 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
California State Teachers Retirement System grew its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 4.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 217,391 shares of the biotechnology company’s stock after purchasing an additional 8,717 […] - 2025-06-05 05:33:03
B. Riley Wealth Advisors Inc. Cuts Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)
B. Riley Wealth Advisors Inc. lowered its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 31.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 12,614 shares of the biotechnology company’s stock after selling 5,892 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in ADMA Biologics were worth […] - 2025-06-02 05:40:55
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $8.77 Million Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 511,526 shares of the biotechnology company’s stock after acquiring an additional 1,559 shares during […] - 2025-06-01 05:37:02
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Tidal Investments LLC
Tidal Investments LLC lessened its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 20.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,351 shares of the biotechnology company’s stock after selling 7,983 shares during the quarter. Tidal Investments LLC’s holdings […] - 2025-05-29 05:10:54
Janus Henderson Group PLC Acquires 15,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
Janus Henderson Group PLC raised its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 16.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 107,161 shares of the biotechnology company’s stock after purchasing an additional 15,000 shares during the period. Janus Henderson Group PLC’s […] - 2025-05-22 06:14:47
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.56 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 7.2% during the 4th quarter, Holdings Channel reports. The firm owned 148,638 shares of the biotechnology company’s stock after purchasing an additional 10,047 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in […] - 2025-05-21 06:14:52
ADMA Biologics (NASDAQ:ADMA) Cut to Sell at StockNews.com
StockNews.com downgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a hold rating to a sell rating in a research report released on Friday morning. Other equities analysts have also issued reports about the stock. Raymond James boosted their price objective on shares of ADMA Biologics from $25.00 to $32.00 and gave the stock […] - 2025-05-12 02:52:44
33,419 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Bought by Mariner LLC
Mariner LLC acquired a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 33,419 shares of the biotechnology company’s stock, valued at approximately $573,000. A number of other hedge funds have also added to […] - 2025-05-01 05:55:00
Analysts Anticipate EZM Will Reach $74
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-09 07:49:44
Vanguard Group Inc. Boosts Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)
Vanguard Group Inc. increased its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,198,796 shares of the biotechnology company’s stock after buying an additional 80,302 shares during the quarter. Vanguard […] - 2025-04-04 05:04:57

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) ADMA holdings

DateNumber of ADMA Shares HeldBase Market Value of ADMA SharesLocal Market Value of ADMA SharesChange in ADMA Shares HeldChange in ADMA Base ValueCurrent Price per ADMA Share HeldPrevious Price per ADMA Share Held
2025-12-03 (Wednesday)168,342USD 3,319,704ADMA holding increased by 79120USD 3,319,7040USD 79,120 USD 19.72 USD 19.25
2025-12-02 (Tuesday)168,342ADMA holding increased by 6000USD 3,240,584ADMA holding increased by 94396USD 3,240,5846,000USD 94,396 USD 19.25 USD 19.38
2025-12-01 (Monday)162,342USD 3,146,188ADMA holding increased by 32468USD 3,146,1880USD 32,468 USD 19.38 USD 19.18
2025-11-28 (Friday)162,342ADMA holding increased by 400USD 3,113,720ADMA holding increased by 14150USD 3,113,720400USD 14,150 USD 19.18 USD 19.14
2025-11-27 (Thursday)161,942USD 3,099,570USD 3,099,5700USD 0 USD 19.14 USD 19.14
2025-11-26 (Wednesday)161,942ADMA holding increased by 1200USD 3,099,570ADMA holding increased by 11716USD 3,099,5701,200USD 11,716 USD 19.14 USD 19.21
2025-11-25 (Tuesday)160,742ADMA holding increased by 2000USD 3,087,854ADMA holding increased by 179701USD 3,087,8542,000USD 179,701 USD 19.21 USD 18.32
2025-11-24 (Monday)158,742ADMA holding increased by 400USD 2,908,153ADMA holding increased by 187837USD 2,908,153400USD 187,837 USD 18.32 USD 17.18
2025-11-21 (Friday)158,342USD 2,720,316ADMA holding increased by 129841USD 2,720,3160USD 129,841 USD 17.18 USD 16.36
2025-11-20 (Thursday)158,342ADMA holding decreased by -1600USD 2,590,475ADMA holding increased by 39400USD 2,590,475-1,600USD 39,400 USD 16.36 USD 15.95
2025-11-19 (Wednesday)159,942ADMA holding increased by 400USD 2,551,075ADMA holding increased by 47861USD 2,551,075400USD 47,861 USD 15.95 USD 15.69
2025-11-18 (Tuesday)159,542ADMA holding increased by 2400USD 2,503,214ADMA holding increased by 80084USD 2,503,2142,400USD 80,084 USD 15.69 USD 15.42
2025-11-17 (Monday)157,142ADMA holding increased by 800USD 2,423,130ADMA holding decreased by -9552USD 2,423,130800USD -9,552 USD 15.42 USD 15.56
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ADMA by Blackrock for IE00BYXG2H39

Show aggregate share trades of ADMA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-02BUY6,00019.88519.050 19.133USD 114,801 18.24
2025-11-28BUY40019.43718.821 18.883USD 7,553 18.23
2025-11-26BUY1,20019.48019.000 19.048USD 22,858 18.22
2025-11-26BUY1,20019.48019.000 19.048USD 22,858 18.22
2025-11-25BUY2,00019.22018.300 18.392USD 36,784 18.21
2025-11-24BUY40018.44017.160 17.288USD 6,915 18.21
2025-11-20SELL-1,60016.95016.230 16.302USD -26,083 18.23 Profit of 3,077 on sale
2025-11-19BUY40016.03015.460 15.517USD 6,207 18.24
2025-11-18BUY2,40015.72015.245 15.292USD 36,702 18.25
2025-11-17BUY80015.61015.220 15.259USD 12,207 18.26
2025-11-14BUY40015.90015.400 15.450USD 6,180 18.28
2025-11-12BUY40016.67015.930 16.004USD 6,402 18.30
2025-11-10BUY39814.79314.180 14.241USD 5,668 18.33
2025-11-06BUY39815.24013.830 13.971USD 5,560 18.37
2025-11-04BUY40015.56014.620 14.714USD 5,886 18.40
2025-10-30BUY2,00015.76015.255 15.306USD 30,611 18.45
2025-10-29BUY80015.53015.750 15.728USD 12,582 18.47
2025-10-22SELL-1,59615.16015.450 15.421USD -24,612 18.55 Profit of 4,995 on sale
2025-10-20BUY79814.69014.800 14.789USD 11,802 18.59
2025-10-17BUY1,99314.36014.600 14.576USD 29,050 18.62
2025-10-15BUY3,17615.09015.600 15.549USD 49,384 18.64
2025-10-03BUY2,75814.66014.890 14.867USD 41,003 18.68
2025-10-02BUY39414.53015.000 14.953USD 5,891 18.70
2025-09-30BUY78614.66014.920 14.894USD 11,707 18.75
2025-09-26BUY78615.61015.630 15.628USD 12,284 18.79
2025-09-25BUY78615.32015.540 15.518USD 12,197 18.81
2025-09-24SELL-6,91915.66016.130 16.083USD -111,278 18.83 Profit of 18,973 on sale
2025-09-18BUY41316.16016.170 16.169USD 6,678 18.84
2025-09-17BUY1,24515.56015.960 15.920USD 19,820 18.86
2025-08-20SELL-1,65217.30017.615 17.583USD -29,048 18.91 Profit of 2,189 on sale
2025-07-30BUY1,65218.59018.925 18.891USD 31,209 18.96
2025-07-17SELL-82617.59018.220 18.157USD -14,998 19.05 Profit of 734 on sale
2025-07-16BUY1,48417.69018.262 18.205USD 27,016 19.05
2025-07-11SELL-3,27218.51018.665 18.650USD -61,021 19.07 Profit of 1,371 on sale
2025-07-07BUY1,22717.88018.350 18.303USD 22,458 19.09
2025-07-02BUY22,49518.14018.190 18.185USD 409,072 19.11
2025-06-20BUY4,57717.74018.193 18.148USD 83,062 19.12
2025-06-11BUY78621.87022.370 22.320USD 17,544 19.07
2025-06-10BUY78620.86021.390 21.337USD 16,771 19.06
2025-06-04SELL-39420.33020.790 20.744USD -8,173 19.02 Loss of -681 on sale
2025-04-23BUY39321.73022.730 22.630USD 8,894 18.34
2025-04-10SELL-3,14418.68019.190 19.139USD -60,173 18.10 Loss of -3,269 on sale
2025-04-08SELL-39317.86019.490 19.327USD -7,596 18.09 Loss of -487 on sale
2025-04-07SELL-39318.40018.890 18.841USD -7,405 18.08 Loss of -298 on sale
2025-04-04SELL-1,96518.01019.000 18.901USD -37,140 18.08 Loss of -1,604 on sale
2025-04-01BUY3,44219.42019.910 19.861USD 68,362 18.04
2025-03-31SELL-1,16119.84019.910 19.903USD -23,107 18.02 Loss of -2,185 on sale
2025-03-21BUY5,05619.80019.820 19.818USD 100,200 17.86
2025-03-14SELL-5,93618.43018.570 18.556USD -110,148 17.76 Loss of -4,718 on sale
2025-03-07SELL-74217.02017.270 17.245USD -12,796 17.78 Profit of 399 on sale
2025-03-04SELL-37117.01017.075 17.069USD -6,332 17.81 Profit of 275 on sale
2025-02-25BUY74415.44015.770 15.737USD 11,708 17.99
2025-02-19SELL-37116.07016.670 16.610USD -6,162 18.14 Profit of 568 on sale
2025-02-13BUY1,11316.08016.150 16.143USD 17,967 18.31
2025-02-12BUY37115.84015.870 15.867USD 5,887 18.36
2025-02-11BUY1,48415.88016.855 16.757USD 24,868 18.41
2024-12-30SELL-12,14717.49017.530 17.526USD -212,888 19.22 Profit of 20,575 on sale
2024-11-18SELL-6,04519.54019.588 19.583USD -118,380 17.89 Loss of -10,228 on sale
2024-11-08SELL-40322.62023.520 23.430USD -9,442 17.28 Loss of -2,480 on sale
2024-10-21SELL-40415.62015.960 15.926USD -6,434 0.00 Loss of -6,434 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ADMA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19554,4137371,447,50538.3%
2025-09-18435,18110,1241,445,62830.1%
2025-09-17543,9082,280876,53062.1%
2025-09-16737,8035391,354,53254.5%
2025-09-15675,6322,5991,376,96449.1%
2025-09-12712,7928981,337,20453.3%
2025-09-11245,17551674,95336.3%
2025-09-10472,1722,2821,124,27042.0%
2025-09-09884,0891,1001,519,25258.2%
2025-09-08766,4091,6581,629,50347.0%
2025-09-05645,121531,156,33255.8%
2025-09-04900,1606,7502,273,75239.6%
2025-09-031,231,9471,3552,927,05342.1%
2025-09-02810,2571,2362,109,45038.4%
2025-08-29303,2896,797702,32943.2%
2025-08-28274,5611,158997,20827.5%
2025-08-27503,2709541,369,10136.8%
2025-08-26256,0120578,12344.3%
2025-08-25513,5452,143940,74954.6%
2025-08-22377,885799825,86145.8%
2025-08-21199,294182788,29625.3%
2025-08-20360,6021,094570,04363.3%
2025-08-19453,129411860,62352.7%
2025-08-18528,8974,2791,092,00848.4%
2025-08-15578,165267914,92463.2%
2025-08-14587,5131,054927,27263.4%
2025-08-13567,7804621,138,20949.9%
2025-08-12674,25402,086,06032.3%
2025-08-111,452,3823003,031,83047.9%
2025-08-08810,29145,4061,626,47849.8%
2025-08-073,063,75385,4145,058,74260.6%
2025-08-06655,2761281,327,47249.4%
2025-08-05428,337955888,07948.2%
2025-08-04446,905400948,77047.1%
2025-08-01502,020917776,35664.7%
2025-07-31398,016208690,21957.7%
2025-07-30628,3311,9091,119,59756.1%
2025-07-29559,0111,732873,51864.0%
2025-07-28537,514318921,68558.3%
2025-07-25495,3174801,415,36735.0%
2025-07-24389,6171,948699,97655.7%
2025-07-23383,7834,2301,967,70119.5%
2025-07-22363,5593,539788,35146.1%
2025-07-21437,9014,001781,01956.1%
2025-07-18518,6855,2371,840,21228.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy